Cambridge, MA, United States of America

Jae-Won Shin

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Harvard College. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae-Won Shin. Retrieved from https://idiyas.com/inventor/jae-won-shin-2m6e2vvh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Jae-Won Shin in Hydrogel Compositions

Introduction

Jae-Won Shin is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of biomedical engineering, particularly in the development of hydrogel compositions. His innovative work focuses on encapsulated cells and their applications in treating various medical conditions.

Latest Patents

Jae-Won Shin holds a patent for "Hydrogel compositions comprising encapsulated cells and methods of use thereof." This invention provides injectable compositions that include cells encapsulated in hydrogel capsules. The methods outlined in the patent aim to promote hematopoiesis and offer treatment or prevention for cardiovascular and immunological disorders in subjects.

Career Highlights

Jae-Won Shin is affiliated with Harvard College, where he continues to advance his research and innovation in the field. His work has garnered attention for its potential impact on medical therapies and regenerative medicine.

Collaborations

Some of his notable coworkers include Angelo S Mao and Stefanie Utech, who contribute to the collaborative research environment at Harvard College.

Conclusion

Jae-Won Shin's innovative work in hydrogel compositions represents a significant advancement in biomedical applications. His contributions have the potential to improve treatment options for various health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…